Drugs / Polvac Grass+Rye
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1/2 | NCT05297760 Comparator | Feb 2022 → Feb 2025 | allergic asthma, seasonal allergic rhinitis | University of Zurich | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Polvac Grass+Rye | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05297760 ↗ |
| Route | Other | “three ILIT injections of the IMD (Polvac Grass+Rye) with 4 weeks intervals” NCT05297760 ↗ |